What is Zacks Research’s Forecast for Nutrien Q2 Earnings?

Nutrien Ltd. (TSE:NTR) – Research analysts at Zacks Research decreased their Q2 2026 earnings estimates for shares of Nutrien in a research report issued on Wednesday, April 15th. Zacks Research analyst Team now anticipates that the company will post earnings of $3.27 per share for the quarter, down from their previous forecast of $3.32. The consensus estimate for Nutrien’s current full-year earnings is $5.34 per share. Zacks Research also issued estimates for Nutrien’s Q3 2026 earnings at $1.03 EPS, FY2026 earnings at $6.07 EPS, Q1 2027 earnings at $0.94 EPS, Q4 2027 earnings at $1.12 EPS and FY2027 earnings at $5.91 EPS.

Nutrien (TSE:NTR) last announced its quarterly earnings data on Wednesday, February 18th. The company reported C$1.14 EPS for the quarter. Nutrien had a net margin of 8.44% and a return on equity of 9.13%. The firm had revenue of C$5.34 billion for the quarter.

Other equities analysts have also issued reports about the company. Wells Fargo & Company upgraded Nutrien from a “hold” rating to a “strong-buy” rating in a report on Friday, March 13th. Jefferies Financial Group raised Nutrien from a “hold” rating to a “strong-buy” rating in a report on Thursday, March 12th. UBS Group lowered Nutrien from a “hold” rating to a “strong sell” rating in a report on Thursday, March 26th. TD Securities lifted their price target on shares of Nutrien from C$72.00 to C$80.00 and gave the company a “buy” rating in a research report on Wednesday, February 18th. Finally, BNP Paribas Exane lowered shares of Nutrien from a “strong-buy” rating to a “hold” rating in a research note on Monday, February 23rd. Two investment analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Nutrien currently has an average rating of “Moderate Buy” and a consensus price target of C$80.00.

Nutrien Trading Up 1.3%

Shares of TSE NTR opened at C$102.15 on Friday. The business has a 50 day simple moving average of C$102.26 and a 200 day simple moving average of C$90.69. Nutrien has a 52 week low of C$72.02 and a 52 week high of C$116.95. The stock has a market cap of C$49.15 billion, a price-to-earnings ratio of 21.92, a PEG ratio of 1.15 and a beta of 0.99. The company has a debt-to-equity ratio of 51.16, a quick ratio of 0.65 and a current ratio of 1.34.

Nutrien News Roundup

Here are the key news stories impacting Nutrien this week:

• Positive Sentiment: Zacks raised its Q3 2026 EPS forecast to $1.03 from $0.99, a small upward revision that could be read as a sign of slightly better mid‑cycle performance. Article Title
• Positive Sentiment: Zacks also increased its Q2 2027 estimate to $2.58 from $2.52, another modest upside for that specific quarter. Article Title
• Negative Sentiment: Several near‑term quarter estimates were trimmed: Q2 2026 to $3.27 (from $3.32), Q1 2027 to $0.94 (from $0.96), and Q4 2027 to $1.12 (from $1.22). These downward tweaks suggest slightly weaker near‑term earnings visibility. Article Title
• Negative Sentiment: Zacks trimmed full‑year outlooks across nearby fiscal years: FY2026 to $6.07 (from $6.11), FY2027 to $5.91 (from $6.02), and FY2028 to $6.32 (from $6.51). The cuts are modest in absolute terms but reduce forward EPS momentum. Article Title
• Negative Sentiment: Additional quarter downgrades include Q4 2026 to $1.11 (from $1.17) and Q3 2027 to $1.28 (from $1.34), reinforcing the broader pattern of small downward revisions. Article Title

About Nutrien

Nutrien is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of growers. We focus on creating long-term value by prioritizing investments that strengthen the advantages of our business across the ag value chain and by maintaining access to the resources and the relationships with stakeholders needed to achieve our goals.